🔹 Horizontal Range Still Intact: Price remains trapped between ~$710 support and ~$965 resistance. These levels have acted as major turning points for over a year — creating a defined trading range.
🔹 False Breakdown & Quick Recovery: After dipping below support, price quickly reclaimed the $795 level — often a signal of seller exhaustion and demand stepping in. This creates a potential bear trap scenario.
🔹 Rejection Zones Marked: Prior attempts to break above ~$965 have failed at the same zone (highlighted in blue), forming a strong but vulnerable ceiling. Each attempt weakens the resistance.
🔹 Current Structure Suggests Stair-Step Higher:
Holding $795 could attract more buyers.
A higher low formation would build pressure for a push toward the top of the range.
Break and hold above $965 opens the door to ATH continuation.
🔹 Trade View:
Entry: ~$790–$800 zone
Stop: Below $709 (red zone — invalidation level)
Target: $965, possibly higher if breakout confirms
💡 Why Price Could Rise:
Price just reclaimed a key level that previously acted as a major pivot.
Strong pharma sector sentiment and
Technical structure supports continuation of the larger range cycle.
🚫 Not financial advice — just charting the probabilities. Watch for confirmation!
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。